# Eszopiclone in the Treatment of Insomnia and Fibromyalgia

> **NCT00392041** · PHASE4 · COMPLETED · sponsor: **Lesley A. Allen, Ph.D.** · enrollment: 36 (actual)

## Conditions studied

- Fibromyalgia
- Insomnia

## Interventions

- **DRUG:** Eszopiclone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00392041
- **Lead sponsor:** Lesley A. Allen, Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392041, "Eszopiclone in the Treatment of Insomnia and Fibromyalgia". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00392041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*